NEW YORK – A startup offering whole-genome and transcriptomic testing for use in

纽约——一家初创公司提供全基因组和转录组测试，用于

in vitro

体外

fertilization (IVF) has recently launched with C$4.6 million (US$3.4 million) in funding.

体外受精 (IVF) 最近已启动，获得了460万加元（340万美元）的资助。

Toronto-based Juniper Genomics will offer sequencing-based testing combining whole-genome and transcriptome sequencing with trio analysis to provide clinically relevant insights into the health of an embryo.

总部位于多伦多的Juniper Genomics将提供基于测序的检测，结合全基因组和转录组测序以及三重分析，为胚胎健康提供临床相关的见解。

In a statement, the firm claimed its test replaces 'all existing forms of preimplantation genetic testing and adds [analysis of] thousands of clinically relevant genetic variants linked to IVF failure, miscarriage, and medical conditions after birth.' The testing does not use polygenic risk scores, the firm noted.

公司声称其测试“取代了所有现有的胚胎植入前遗传学检测形式，并增加了与体外受精失败、流产以及出生后医学状况相关的数千种临床相关基因变异的分析。”该公司还指出，该测试不使用多基因风险评分。

.

。

Company Ventures led the round, joined by Innospark Ventures, MBX Capital, Amboy Street Ventures, Dria Ventures, and Blue Collective.

公司风险投资公司领投了这一轮，英诺斯帕克风险投资公司、MBX资本、阿姆博伊街风险投资公司、德里亚风险投资公司和蓝色集体跟投。

Juniper Genomics said it plans to use the funds to expand its commercial reach, grow its bioinformatics and clinical teams, and pursue research partnerships.

Juniper Genomics 表示，计划利用这笔资金扩大其商业覆盖范围、扩充其生物信息学和临床团队，并寻求研究合作。

'The IVF journey can be emotionally exhausting and financially overwhelming — and the current standard of care for embryo testing has a low success rate that often leaves patients with more questions than answers,' Juniper Genomics CEO and Cofounder Jeremy Grushcow said in a statement. 'It's important for people to know that failed transfers aren't anyone's fault — most embryos simply aren't viable.

“试管婴儿的过程可能会让人情感上疲惫不堪，经济上压力巨大——而目前胚胎检测的护理标准成功率较低，常常让患者产生更多疑问而非答案，”Juniper Genomics首席执行官兼联合创始人杰里米·格鲁什考在一份声明中表示。“重要的是，人们要知道移植失败并不是任何人的错——大多数胚胎根本无法存活。”

We can do better by improving the chances of success on the very first try. We work in partnership with IVF clinicians to pair cutting-edge science with rigorous ethical standards, ensuring families receive clear, responsible, and compassionate care every step of the way.'.

通过提高首次尝试的成功率，我们可以做得更好。我们与体外受精临床医生合作，将尖端科学与严格的伦理标准相结合，确保家庭在每一步都能得到清晰、负责且富有同情心的关怀。

The firm has also received unspecified grant funding from Genome Canada and Genome Quebec.

该公司还从加拿大基因组和魁北克基因组获得了数额不详的资助。